Phosphorylation Of P53 Protein Triggered By Epstein-Barr Virus Latent Membrane Protein 1 In The Carcinogenesis Of Nasopharyngeal Carcinoma
Lili Li,Yongguang Tao,Yun Nian Tan,Min Tang,Sai Wah Tsao,Ya Cao
IF: 11.2
2006-01-01
Cancer Research
Abstract:Proc Amer Assoc Cancer Res, Volume 47, 2006 4439 Nasopharyngeal carcinoma is a malignancy which is highly associated with the Epstein-Barr virus (EBV). It has been proposed that NPC initiation depends on EBV expression. As the key oncogenic protein, EBV encoded latent memebrane protein 1 (LMP1) plays an important role in carcinogenesis of NPC. However, studies of LMP1 have been mainly focused on the B lymphoma cells and other tumor cells. So using the immortalized NP cells established from primary nonmalignant nasopharyngeal epithelial cells may represent a novel cell model system for studying the mechanism involved in the tumorigenesis of NPC. p53 is an important tumor-suppressor gene, which is believed to be important in multistage human carcinogenesis. Phoshporylation of p53 protein is likely to play the key role in regulating its activity. Mechanisms other than mutation can cause p53 inactivation in human malignancies, for instance the binding of viral proteins. In NPC, p53 protein accumulates but mutation of p53 gene is not common. It is reported that the expression of p53 correlated with malignant stage. To date, the function of p53 remains uncertain in NPC. In this study, we choose immortalized nasopharyngeal carcinoma cells NP69, and respectively stable transfected control vector (NP69-pLNSX), LMP1 plasmid (NP69-LMP1) as an experimental model. LMP1 could induce many phenotypic changes in NP69 cells, including morphologic transformation, anchorage-independent growth, resistance to serum free-induced cell death, and enhanced cell migration and invasion. We present data to show that p53 is not mutated in the carcinogenesis of NPC. LMP1 can upregulate the expression of p53 protein and promote the accumulation of p53 protein in the nucleus. Ionizing radiation (5Gy) and reporter gene assay indicated that p53 is functional in LMP1-expressing cells. More interestingly, p53 can be activated and phosphorylated clearly at serine 15, serine 20, serine 392 and threonine 81 induced by LMP1. Transient transfection assay further confirm that LMP1 can regulate the phosphorylation of p53. We also provide evidence that LMP1-induced phosphorylation of p53 at serine 15 is directly by ERKs kinase; at serine 20 and threonine 81 by JNK kinase, at serine 392 by p38 kinase. We find that LMP1 can promote ERK, JNK and p38 to form the complex with p53 following the initiation of LMP1 expression. These results strongly suggest that ERKs, JNK and p38 kinase have a direct role in LMP1-induced phsophorylation of p53 at multiple site in the carcinogenesis of nasopharyngeal carcinoma.
What problem does this paper attempt to address?